Evidence map›Paper›PMID 24530296›Full record

ArticleDevelopmental cell2014

Prostaglandin E2 regulates liver versus pancreas cell-fate decisions and endodermal outgrowth.

Sahar Nissim, Richard I Sherwood, Julia Wucherpfennig, Diane Saunders, James M Harris, Virginie Esain, Kelli J Carroll, Gregory M Frechette, Andrew J Kim, Katie L Hwang and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Developmental cell, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Intestinal precursors avoid being misinduced to liver cells by activating Cdx-Wnt inhibition cascade.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  8. Article
  9. Prostaglandin signaling regulates renal multiciliated cell specification and maturation.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  10. Review
  11. eLife · 2018
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Disease models & mechanisms · 2017
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Sahar NissimGastroenterology Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Genetics Division, Brigham and Women's Hospital, Boston, MA 02115, USA; Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Richard I SherwoodGenetics Division, Brigham and Women's Hospital, Boston, MA 02115, USA.
Julia WucherpfennigGenetics Division, Brigham and Women's Hospital, Boston, MA 02115, USA.
Diane SaundersGenetics Division, Brigham and Women's Hospital, Boston, MA 02115, USA.
James M HarrisDepartment of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
Virginie EsainDepartment of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
Kelli J CarrollDepartment of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
Gregory M FrechetteDepartment of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
Andrew J KimGenetics Division, Brigham and Women's Hospital, Boston, MA 02115, USA.
Katie L HwangGenetics Division, Brigham and Women's Hospital, Boston, MA 02115, USA.
Claire C CuttingGenetics Division, Brigham and Women's Hospital, Boston, MA 02115, USA.
Susanna ElledgeGenetics Division, Brigham and Women's Hospital, Boston, MA 02115, USA.
Trista E NorthDepartment of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA. Electronic address: tnorth@bidmc.harvard.edu.
Wolfram GoesslingGastroenterology Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Genetics Division, Brigham and Women's Hospital, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA; Dana-Farber Cancer Institute, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. Electronic address: wgoessling@partners.org.
Brigham and Women's Hospital · USHarvard University · USBeth Israel Deaconess Medical Center · USBroad Institute · USDana-Farber Cancer Institute · US

Funding

Medical Scientist Training ProgramT32GM007753 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WALENSKY, LOREN DAVID · 1985 to 2021
$50.0M
ALIMENTARY TRACT RESEARCH IN HEALTH AND DISEASET32DK007533 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI BLUMBERG, RICHARD S · 1986 to 2020
$5.3M
Estrogen Regulation of Hepatic GrowthR01DK090311 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI GOESSLING, WOLFRAM · 2011 to 2020
$4.9M
Characterization of regulators of hemotopoietic stem cell homeostasisK01DK080226 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI NORTH, TRISTA E. · 2009 to 2013
$713k
Predictive transcription factor modeling to program endodermal cell fatesK01DK101684 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI SHERWOOD, RICHARD I · 2014 to 2018
$670k
PGE2 and wnt signaling during zebrafish liver development and regenerationR03DK085445 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI GOESSLING, WOLFRAM · 2010 to 2011
$177k
NIDDK NIH HHS K01DK080226NIDDK NIH HHS K01 DK101684NIDDK NIH HHS R01 DK090311NIDDK NIH HHS R01DK090311NIDDK NIH HHS R03 DK085445NIDDK NIH HHS R03DK085445NIDDK NIH HHS T32 DK007533NIGMS NIH HHS T32 GM007753
6 · The paper itself

Abstract

The liver and pancreas arise from common endodermal progenitors. How these distinct cell fates are specified is poorly understood. Here we describe prostaglandin E2 (PGE2) as a regulator of endodermal fate specification during development. Modulating PGE2 activity has opposing effects on liver versus pancreas specification in zebrafish embryos as well as mouse endodermal progenitors. The PGE2 synthetic enzyme cox2a and receptor ep2a are patterned such that cells closest to PGE2 synthesis acquire a liver fate, whereas more distant cells acquire a pancreas fate. PGE2 interacts with the bmp2b pathway to regulate fate specification. At later stages of development, PGE2 acting via the ep4a receptor promotes outgrowth of both the liver and pancreas. PGE2 remains important for adult organ growth, as it modulates liver regeneration. This work provides in vivo evidence that PGE2 may act as a morphogen to regulate cell-fate decisions and outgrowth of the embryonic endodermal anlagen.

Indexed as

Cell LineageAnimalsBone Morphogenetic Protein 2Cell DifferentiationDinoprostoneEndodermLiverMiceOrganogenesisPancreasSignal TransductionZebrafishZebrafish Proteinsbmp2b protein, zebrafishBmp2 protein, mouseBone Morphogenetic Protein 2DinoprostoneZebrafish Proteins

Identifiers

PMID24530296
PMCPMC4006117
OpenAlexW2012155951

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.